Mats Ehinger
Overview
Explore the profile of Mats Ehinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1904
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lindquist K, Cortas G, Hashemi Y, Rajabian N, Ehinger M
Diagn Cytopathol
. 2024 Jun;
52(9):524-532.
PMID: 38853534
Introduction: Lymph node fine-needle aspiration cytology (LN-FNAC) is a common, rapid, minimally invasive and cost-effective diagnostic method. For mediastinal lymph nodes, endobronchial ultrasound (EBUS) guided LN-FNAC is a first-line investigation...
2.
Ehinger M, Bene M
Virchows Arch
. 2024 May;
485(4):591-604.
PMID: 38805049
The diagnosis of lymphoma relies mainly on clinical examination and laboratory explorations. Among the latter, morphological and immunohistochemical analysis of a tissue biopsy are the cornerstones for proper identification and...
3.
Rodriguez-Zabala M, Ramakrishnan R, Reinbach K, Ghosh S, Oburoglu L, Falques-Costa A, et al.
Blood Adv
. 2023 Jul;
7(18):5382-5395.
PMID: 37505194
Acute myeloid leukemia (AML) is initiated and propagated by leukemia stem cells (LSCs), a self-renewing population of leukemia cells responsible for therapy resistance. Hence, there is an urgent need to...
4.
Caputo A, Fraggetta F, Cretella P, Cozzolino I, Eccher A, Girolami I, et al.
Cancer Cytopathol
. 2023 Jul;
131(11):679-692.
PMID: 37418195
Background: After a series of standardized reporting systems in cytopathology, the Sydney system was recently introduced to address the need for reproducibility and standardization in lymph node cytopathology. Since then,...
5.
Bekassy Z, Ehinger M, Pronk L, Pronk C
J Clin Immunol
. 2022 Jul;
42(7):1401-1404.
PMID: 35788939
No abstract available.
6.
Porwit A, Violidaki D, Axler O, Lacombe F, Ehinger M, Bene M
Cytometry B Clin Cytom
. 2022 Feb;
102(2):134-142.
PMID: 35150187
Background: The Flow-Self Organizing Maps (FlowSOM) artificial intelligence (AI) program, available within the Bioconductor open-source R-project, allows for an unsupervised visualization and interpretation of multiparameter flow cytometry (MFC) data. Methods:...
7.
Pettersson L, Johansson Alm S, Almstedt A, Chen Y, Orrsjo G, Shah-Barkhordar G, et al.
Int J Lab Hematol
. 2021 May;
43(4):664-674.
PMID: 34053184
Introduction: Reverse transcriptase quantitative PCR (RT-qPCR) is considered the method of choice for measurable residual disease (MRD) assessment in NPM1-mutated acute myeloid leukemia (AML). MRD can also be determined with...
8.
Al-Abbadi M, Barroca H, Bode-Lesniewska B, Calaminici M, Chhieng D, Cozzolino I, et al.
Eur J Haematol
. 2021 May;
107(2):295-296.
PMID: 33961309
No abstract available.
9.
Rosso A, Juliusson G, Lorenz F, Lehmann S, Derolf A, Deneberg S, et al.
Leuk Lymphoma
. 2021 Mar;
62(8):1973-1981.
PMID: 33719843
The Swedish national guidelines for treatment of acute myeloid leukemia (AML) recommend analysis of measurable residual disease (MRD) by multiparameter flow cytometry (MFC) in bone marrow in the routine clinical...
10.
Pettersson L, Holmgren B, Juliusson G, Lazarevic V, Ehinger M
Leuk Lymphoma
. 2021 Mar;
62(8):1958-1966.
PMID: 33711909
AML with mutated occurs in all age groups. Yet, the mutational pattern is not extensively studied in the very old, which may hamper appropriate risk assessment. Herein we examined 22...